Cargando…
Surveying the Oral Drug Delivery Avenues of Novel Chitosan Derivatives
Chitosan has come a long way in biomedical applications: drug delivery is one of its core areas of imminent application. Chitosan derivatives are the new generation variants of chitosan. These modified chitosans have overcome limitations and progressed in the area of drug delivery. This review brief...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182633/ https://www.ncbi.nlm.nih.gov/pubmed/35683804 http://dx.doi.org/10.3390/polym14112131 |
_version_ | 1784724083180568576 |
---|---|
author | Sivanesan, Iyyakkannu Tasneem, Shadma Hasan, Nazim Shin, Juhyun Muthu, Manikandan Gopal, Judy Oh, Jae-Wook |
author_facet | Sivanesan, Iyyakkannu Tasneem, Shadma Hasan, Nazim Shin, Juhyun Muthu, Manikandan Gopal, Judy Oh, Jae-Wook |
author_sort | Sivanesan, Iyyakkannu |
collection | PubMed |
description | Chitosan has come a long way in biomedical applications: drug delivery is one of its core areas of imminent application. Chitosan derivatives are the new generation variants of chitosan. These modified chitosans have overcome limitations and progressed in the area of drug delivery. This review briefly surveys the current chitosan derivatives available for biomedical applications. The biomedical applications of chitosan derivatives are revisited and their key inputs for oral drug delivery have been discussed. The limited use of the vast chitosan resources for oral drug delivery applications, speculated to be probably due to the interdisciplinary nature of this research, is pointed out in the discussion. Chitosan-derivative synthesis and practical implementation for oral drug delivery require distinct expertise from chemists and pharmacists. The lack of enthusiasm could be related to the inadequacy in the smooth transfer of the synthesized derivatives to the actual implementers. With thiolated chitosan derivatives predominating the oral delivery of drugs, the need for representation from the vast array of ready-to-use chitosan derivatives is emphasized. There is plenty to explore in this direction. |
format | Online Article Text |
id | pubmed-9182633 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91826332022-06-10 Surveying the Oral Drug Delivery Avenues of Novel Chitosan Derivatives Sivanesan, Iyyakkannu Tasneem, Shadma Hasan, Nazim Shin, Juhyun Muthu, Manikandan Gopal, Judy Oh, Jae-Wook Polymers (Basel) Review Chitosan has come a long way in biomedical applications: drug delivery is one of its core areas of imminent application. Chitosan derivatives are the new generation variants of chitosan. These modified chitosans have overcome limitations and progressed in the area of drug delivery. This review briefly surveys the current chitosan derivatives available for biomedical applications. The biomedical applications of chitosan derivatives are revisited and their key inputs for oral drug delivery have been discussed. The limited use of the vast chitosan resources for oral drug delivery applications, speculated to be probably due to the interdisciplinary nature of this research, is pointed out in the discussion. Chitosan-derivative synthesis and practical implementation for oral drug delivery require distinct expertise from chemists and pharmacists. The lack of enthusiasm could be related to the inadequacy in the smooth transfer of the synthesized derivatives to the actual implementers. With thiolated chitosan derivatives predominating the oral delivery of drugs, the need for representation from the vast array of ready-to-use chitosan derivatives is emphasized. There is plenty to explore in this direction. MDPI 2022-05-24 /pmc/articles/PMC9182633/ /pubmed/35683804 http://dx.doi.org/10.3390/polym14112131 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Sivanesan, Iyyakkannu Tasneem, Shadma Hasan, Nazim Shin, Juhyun Muthu, Manikandan Gopal, Judy Oh, Jae-Wook Surveying the Oral Drug Delivery Avenues of Novel Chitosan Derivatives |
title | Surveying the Oral Drug Delivery Avenues of Novel Chitosan Derivatives |
title_full | Surveying the Oral Drug Delivery Avenues of Novel Chitosan Derivatives |
title_fullStr | Surveying the Oral Drug Delivery Avenues of Novel Chitosan Derivatives |
title_full_unstemmed | Surveying the Oral Drug Delivery Avenues of Novel Chitosan Derivatives |
title_short | Surveying the Oral Drug Delivery Avenues of Novel Chitosan Derivatives |
title_sort | surveying the oral drug delivery avenues of novel chitosan derivatives |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182633/ https://www.ncbi.nlm.nih.gov/pubmed/35683804 http://dx.doi.org/10.3390/polym14112131 |
work_keys_str_mv | AT sivanesaniyyakkannu surveyingtheoraldrugdeliveryavenuesofnovelchitosanderivatives AT tasneemshadma surveyingtheoraldrugdeliveryavenuesofnovelchitosanderivatives AT hasannazim surveyingtheoraldrugdeliveryavenuesofnovelchitosanderivatives AT shinjuhyun surveyingtheoraldrugdeliveryavenuesofnovelchitosanderivatives AT muthumanikandan surveyingtheoraldrugdeliveryavenuesofnovelchitosanderivatives AT gopaljudy surveyingtheoraldrugdeliveryavenuesofnovelchitosanderivatives AT ohjaewook surveyingtheoraldrugdeliveryavenuesofnovelchitosanderivatives |